102 related articles for article (PubMed ID: 3740468)
41. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1991 Oct; 15(1):33-55. PubMed ID: 1747567
[TBL] [Abstract][Full Text] [Related]
42. Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice.
Garaci E; Mastino A; Jezzi T; Riccardi C; Favalli C
Cell Immunol; 1987 Apr; 106(1):43-52. PubMed ID: 3568147
[TBL] [Abstract][Full Text] [Related]
43. Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone.
Wolfe HJ; Bitman WR; Voelkel EF; Griffiths HJ; Tashjian AH
Lab Invest; 1978 Feb; 38(2):208-15. PubMed ID: 628205
[TBL] [Abstract][Full Text] [Related]
44. A quantitative histologic analysis of the growing long bone metaphysis.
Kimmel DB; Jee WS
Calcif Tissue Int; 1980; 32(2):113-22. PubMed ID: 6773628
[TBL] [Abstract][Full Text] [Related]
45. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
Bennett A; Carroll MA; Melhuish PB; Stamford IF
Br J Cancer; 1985 Aug; 52(2):245-9. PubMed ID: 4027166
[TBL] [Abstract][Full Text] [Related]
46. Study on ectopic calcification in bone marrow of rat tibia caused by vinblastine.
Tamura Y
Bull Tokyo Med Dent Univ; 1986 Mar; 33(1):9-22. PubMed ID: 3457645
[TBL] [Abstract][Full Text] [Related]
47. The inhibition of cell mediated cytotoxicity by 16,16 dimethyl PGE2.
Flye MW; Yu S
Transplant Proc; 1989 Feb; 21(1 Pt 1):1156-7. PubMed ID: 2705217
[No Abstract] [Full Text] [Related]
48. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
[TBL] [Abstract][Full Text] [Related]
49. The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia.
Miller SC; Jee WS
Calcif Tissue Res; 1977 Oct; 23(3):207-14. PubMed ID: 143335
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the effects of prostaglandin E2 and parathyroid hormone on plasma calcium concentration and osteoclast function.
Vanderwiel CJ; Talmage RV
Endocrinology; 1979 Sep; 105(3):588-94. PubMed ID: 467320
[No Abstract] [Full Text] [Related]
51. Cytoprotective effect of 16,16-dimethyl prostaglandin (PGE2) on ischemic splanchnic injuries in the rat.
Dawiskiba J; Isaksson B; Jeppsson B; Hägerstrand I; Bengmark S
Eur Surg Res; 1984; 16(2):77-83. PubMed ID: 6698078
[TBL] [Abstract][Full Text] [Related]
52. Effect of 16,16-dimethyl prostaglandin E2 on small intestinal mucosa in suckling rats.
Koelz HR; Lentze MJ; Müller OM; Halter F
Eur J Clin Invest; 1987 Aug; 17(4):293-300. PubMed ID: 3117565
[TBL] [Abstract][Full Text] [Related]
53. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
[TBL] [Abstract][Full Text] [Related]
54. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats.
Nagai H; Tsukuda R; Mayahara H
Bone; 1995 Mar; 16(3):367-73. PubMed ID: 7786640
[TBL] [Abstract][Full Text] [Related]
55. Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia.
Miller SC; Jee WS
Calcif Tissue Res; 1975 Sep; 18(3):215-31. PubMed ID: 810231
[TBL] [Abstract][Full Text] [Related]
56. Effects of neonatal estrogenization on rat bone development: a histomorphometric study.
Aceitero J; Gaytan F; Ranz FB
Calcif Tissue Int; 1987 Apr; 40(4):189-93. PubMed ID: 3107771
[TBL] [Abstract][Full Text] [Related]
57. Effect on bone growth of daily versus alternate-day corticosteroid administration: an experimental study.
Sheagren JN; Jowsey J; Bird DC; Gurton ME; Jacobs JB
J Lab Clin Med; 1977 Jan; 89(1):120-30. PubMed ID: 830772
[TBL] [Abstract][Full Text] [Related]
58. The anabolic action of 17 beta-estradiol (E2) on rat trabecular bone is suppressed by (3-amino-1-hydroxypropylidene)-1-bisphosphonate (AHPrBP).
Abe T; Chow JW; Lean JM; Chambers TJ
Bone Miner; 1992 Oct; 19(1):21-9. PubMed ID: 1422303
[TBL] [Abstract][Full Text] [Related]
59. Hypercalcaemic responses to 16,16-dimethyl prostaglandin E2, a stable prostaglandin E2 analogue in chicks.
Kirby GC; Dacke CG
J Endocrinol; 1983 Oct; 99(1):115-22. PubMed ID: 6631302
[TBL] [Abstract][Full Text] [Related]
60. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model.
Friedlaender GE; Tross RB; Doganis AC; Kirkwood JM; Baron R
J Bone Joint Surg Am; 1984 Apr; 66(4):602-7. PubMed ID: 6707039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
